Inhibiting the Epidermal Growth Factor Receptor (EGFR) to improve clinical outcomes for patients with Squamous Cell Carcinoma of the Head and Neck (SCCHN)

ResearchSpace Repository

Files in this item

Find Full text

This item appears in the following Collection(s)

http://creativecommons.org/licenses/by-nc-sa/3.0/nz/ Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/3.0/nz/

Share

Search ResearchSpace


Advanced Search

Browse

Statistics